HomeGRCE • NASDAQ
add
Grace Therapeutics, Inc
Previous close
$2.97
Day range
$2.95 - $3.03
Year range
$1.75 - $4.97
Market cap
41.55M USD
Avg Volume
80.08K
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
Market news
Financials
Income Statement
Revenue
Net income
| (USD) | Jun 2025info | Y/Y change |
|---|---|---|
Revenue | — | — |
Operating expense | 3.09M | -37.74% |
Net income | -3.36M | -28.47% |
Net profit margin | — | — |
Earnings per share | -0.29 | 12.15% |
EBITDA | -3.09M | 37.77% |
Effective tax rate | — | — |
Balance Sheet
Total assets
Total liabilities
| (USD) | Jun 2025info | Y/Y change |
|---|---|---|
Cash and short-term investments | 20.00M | 3.07% |
Total assets | 69.80M | 0.12% |
Total liabilities | 6.26M | -39.59% |
Total equity | 63.55M | — |
Shares outstanding | 13.83M | — |
Price to book | 0.65 | — |
Return on assets | -10.90% | — |
Return on capital | -11.87% | — |
Cash Flow
Net change in cash
| (USD) | Jun 2025info | Y/Y change |
|---|---|---|
Net income | -3.36M | -28.47% |
Cash from operations | -1.80M | 49.92% |
Cash from investing | — | — |
Cash from financing | -327.00K | — |
Net change in cash | -2.13M | 41.07% |
Free cash flow | -1.18M | 39.69% |
About
Founded
2002
Website
Employees
6
